Company Filing History:
Years Active: 2001
Title: The Innovations of Francois Montier
Introduction
Francois Montier is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmacology, particularly in the development of synergistic combinations for medical treatments. His work focuses on the antagonist effects on neurokinin receptors, which are crucial in addressing various diseases.
Latest Patents
Montier holds a patent for a synergizing combination having an antagonist effect on NK1 and NK2 receptors. This innovative approach involves associations characterized by at least one product with antagonist activity on NK1 receptors and at least one product with antagonist activity on NK2 receptors. These associations are particularly useful in treating diseases involving substance P and/or neurokinin A. He has 1 patent to his name.
Career Highlights
Francois Montier is associated with Aventis Pharma S.A., a prominent pharmaceutical company. His work at Aventis has allowed him to explore and develop groundbreaking treatments that have the potential to improve patient outcomes significantly. His expertise in pharmacology and receptor interactions has positioned him as a valuable asset in the field.
Collaborations
Montier has collaborated with Claude Garret, a fellow professional in the industry. Their partnership has likely contributed to the advancement of their research and the development of innovative solutions in pharmacology.
Conclusion
Francois Montier's contributions to the field of pharmacology through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments, showcasing the impact of dedicated research and innovation.